newsfilter
← Latest News
Business Wire·

MyMD Pharmaceuticals to Present its Novel Therapeutic Platforms for Extending Healthy Lifespan at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15

MyMD to highlight its development pipeline for MYMD-1, an immunometabolic regulator, and Supera-CBD, a synthetic cannabidiol derivative MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) ("MyMD" or "the Company"), a clinical stage pharmaceutical company commit